MS
EW icon

Maven Securities’s Edwards Lifesciences EW Stock Holding History

Maven Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,500
Closed -$1.44M – 855
2024
Q4 		$1.44M Buy
19,500
+100
+0.5% +$7K 0.04% 346
2024
Q3 		$1.28M Sell
19,400
-200
-1% -$14.5K 0.02% 445
2024
Q2 		$1.81M Buy
+19,600
New +$1.74M 0.04% 386
2024
Q1 		– Sell
-4,100
Closed -$313K – 576
2023
Q4 		$313K Buy
4,100
+400
+11% +$27.8K 0.01% 799
2023
Q3 		$256K Sell
3,700
-2,400
-39% -$193K ﹤0.01% 985
2023
Q2 		$576K Buy
+6,100
New +$530K 0.01% 587
2022
Q2 		– Sell
-600
Closed -$71K – 953
2022
Q1 		$71K Sell
600
-6,600
-92% -$740K ﹤0.01% 892
2021
Q4 		$933K Buy
+7,200
New +$840K 0.03% 371

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Maven Securities's EW Position: Q1 2025 in Review

Maven Securities sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 2,941 shares — an estimated $218K sold.

Maven Securities first reported a position in EW in Q4 2020 and held it in 4 quarters. The position peaked at $1.55M in Q4 2020. 1,204 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Maven Securities reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 2,941 Edwards Lifesciences shares in Q1 2025, an estimated $218K.
  • Maven Securities first reported a position in Edwards Lifesciences in Q4 2020 and held it in 4 quarters.
  • Maven Securities's Edwards Lifesciences position peaked at $1.55M in Q4 2020.
  • 1,204 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.